Literature DB >> 23106664

Sensitization induces hypersensitivity in trigeminal nerve.

X Wang1, H Liang, C Zhou, M Xu, L Xu.   

Abstract

BACKGROUND AND AIMS: Trigeminal neuralgia is one of the chronic neuropathic pains. The aetiology remains unclear. Chronic inflammation is proposed playing a role in the pathogenesis of trigeminal neuralgia. This study aims to assess the role of allergic inflammation in the pathological status of trigeminal neuralgia.
METHODS: Allergic inflammation was induced in the infraorbital skin of rats. The expression of 5-HT receptor 3 (R3) in the trigeminal nerve and mastocytosis in the local tissue were observed by immunohistochemistry. The hyperalgesia status of the trigeminal nerve was determined by quantitatively recording the head-withdrawal threshold to mechanical stimulation of the infraorbital nerve territory.
RESULTS: After sensitization, the expression of 5-HT R3 in the trigeminal nerve and the frequency of mast cells were markedly increased in the epidermal tissue of the infraorbital area. Applying exogenous 5-HT to the local tissue also increased the expression of 5-HT R3 in the trigeminal nerve. The threshold of mechanical allodynia to stimuli was significantly lower in sensitized rats than control rats, which could be blocked by pre-treatment with either 5-HT R3 antagonists, or neurokinin-1 antagonists, or mast cell stabilizers.
CONCLUSIONS: Allergic inflammation can induce the overexpression of 5-HT R3 in the trigeminal nerve to induce the hyperalgesia status in the trigeminal nerve. The 5-HT R3 may be a therapeutic target in the treatment of trigeminal neuralgia.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23106664     DOI: 10.1111/j.1365-2222.2012.04051.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  1 in total

1.  Neuronal plasticity of trigeminal ganglia in mice following nerve injury.

Authors:  Randi Lynds; Chuang Lyu; Gong-Wei Lyu; Xie-Qi Shi; Annika Rosén; Kamal Mustafa; Tie-Jun Sten Shi
Journal:  J Pain Res       Date:  2017-02-09       Impact factor: 3.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.